NK cells as a possible new player in atopic dermatitis.
暂无分享,去创建一个
[1] Jonathan R. Brestoff,et al. Blood natural killer cell deficiency reveals an immunotherapy strategy for atopic dermatitis , 2020, Science Translational Medicine.
[2] T. Honda,et al. Reconciling innate and acquired immunity in atopic dermatitis. , 2020, The Journal of allergy and clinical immunology.
[3] T. Nomura,et al. The epithelial immune microenvironment (EIME) in atopic dermatitis and psoriasis , 2018, Nature Immunology.
[4] S. Koyasu,et al. The group 2 innate lymphoid cell (ILC2) regulatory network and its underlying mechanisms , 2018, Immunological reviews.
[5] T. Bieber,et al. Atopic dermatitis , 2018, Nature Reviews Disease Primers.
[6] Xiaolu Yang,et al. NK Cells Alleviate Lung Inflammation by Negatively Regulating Group 2 Innate Lymphoid Cells , 2017, The Journal of Immunology.
[7] D. Leung,et al. Recent considerations in the use of recombinant interferon gamma for biological therapy of atopic dermatitis , 2016, Expert opinion on biological therapy.
[8] B. Fensterheim,et al. Immunotoxicity: Role of NK Cells and IFN-Mediated - IL-15 Superagonist , 2022 .
[9] J. Silverberg,et al. Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis , 2019, The Journal of allergy and clinical immunology.
[10] J. Common,et al. Insights into atopic dermatitis gained from genetically defined mouse models. , 2019, The Journal of allergy and clinical immunology.